Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MWN109 Tablets Phase II Extension in Overweight or Obese Non‑diabetic Adults
CTR20260203Phase 2Active
- Sponsor
- Shanghai Minwei Biotechnology Co., Ltd.
- Start
- Mar 2026
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of MWN109 in Overweight, obesity, sponsored by Shanghai Minwei Biotechnology Co., Ltd.. Started Mar 2026; status: active.
02
Drugs
MWN109
03
Conditions
Overweightobesity
Beyond the preview
Go deeper on CTR20260203.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20260203.